🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMetabolic Health & DiabetesAdiponectin and leptin changes on GLP-1 therapy Page 2

Adiponectin and leptin changes on GLP-1 therapy

DataDave Fri, Jun 5, 2026 at 8:47 AM 15 replies 341 viewsPage 2 of 3
BiostatsBrad
Member
456
2,345
Jul 2024
Durham, NC
Jun 5, 2026 at 7:57 PM#6
DataDave said:
The mental-health dimension is under-measured in the trial literature and the reports here are consistent enough to take seriously.
DataDave said:
...mental health should only be used alongside therapy...

I'd say therapy should be AVAILABLE to all GLP-1 patients, but requiring it as a precondition for treatment would create an access barrier.

Not everyone can afford therapy. Not everyone needs it. Some people do just fine with medication + lifestyle changes. But for those with emotional eating, body image issues, or disordered eating history, therapy is extremely valuable.

My recommendation: make mental health screening part of the initial assessment, offer therapy as a recommended adjunct, but don't gatekeep medication access behind it.

Last edited: Jun 5, 2026 at 8:57 PM
22 17LindaRN_retired, tommy_boulder, hyun_seoul and 19 others
Reply Quote Save Share Report
stefan_berlin
Member
234
1,123
Oct 2024
Berlin, DE
Jun 6, 2026 at 12:24 AM#7

Following on from Dr.DermMIA — and this may be the naive question:

How long did you give it before you decided it was working?

Last edited: Jun 6, 2026 at 3:24 AM
21 16JessicaH_TX, KevinCompounds, TirzTom and 18 others
Reply Quote Save Share Report
Dr.GutHealth
Senior Member
1,456
7,890
Mar 2024
Minnesota
Jun 6, 2026 at 4:51 AM#8
BiostatsBrad said:
DataDave said: ...mental health should only be used alongside therapy...

Recovering from an eating disorder and using mental health: this is a complex situation and I want to be transparent about it.

I have a history of binge eating disorder. My psychiatrist, therapist, and prescribing doctor all collaborate on my care. The GLP-1 agonist has actually been therapeutic — it removes the biological urgency of binge impulses without relying on restriction.

This is NOT appropriate for all ED patients. Anorexia, bulimia, and restrictive EDs require different approaches. But for BED specifically, the evidence and my personal experience are positive. Always involve your mental health team.

20 15jennifer_SEA, tyler_CSCS, VanRx_Mike and 17 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
DataDave
Senior Member
1,678
8,901
Apr 2024
Washington
Online
Jun 6, 2026 at 9:17 AM#9

Reporting back.

Follow-up — I put something in the gap where food used to be rather than waiting for the gap to close on its own. That was the part nobody told me.

Last edited: Jun 6, 2026 at 10:17 AM
19 14amsterdam_pete, LondonLisa, mike_nyc and 16 others
Reply Quote Save Share Report
ingrid_STO
Member
345
1,456
Jul 2024
Stockholm, SE
Jun 7, 2026 at 6:37 AM#10
Dr.GutHealth said:
Recovering from an eating disorder and using mental health: this is a complex situation and I want to be transparent about it.

When to call your doctor about mental health side effects — a reference I wish I'd had:

Call immediately:

  • Severe abdominal pain (could be pancreatitis)
  • Vision changes (thyroid concern)
  • Lump in neck (thyroid nodule)
  • Severe vomiting/can't keep fluids down for 24h+

Schedule an appointment:

  • Persistent nausea beyond 4 weeks
  • Significant hair loss
  • Mood changes or depression
  • Gallbladder symptoms (RUQ pain after eating)
37 12WendyG_ATL, SaraMom3, Dr.MetabolicMD and 34 others
Reply Quote Save Share Report

Similar Threads

SUSTAIN-6 to SELECT — the cardiovascular evidence timeline14 replies
GLP-1 and insulin resistance — HOMA-IR improvement data17 replies
Metabolic syndrome reversal criteria — how GLP-1 addresses all 55 replies
A1C target achievement rates — sema vs tirz comparison8 replies
SURPASS-CVOT: tirzepatide cardiovascular outcomes trial design3 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register